Thomas H. Davis MD

Contact Information:

Phone: (603) 650-8626

Fax: (603) 650-9496

Email: not given

Institution Affiliations:

Associate Professor of Medicine (Hematology/Oncology)

Department of: MEDICINE

Section: Hematology/Oncology

Specialty: Hematology

Joined Staff: 1992

Cancer Center Membership:

Head and Neck Clinical Oncology Group

Hematology/Oncology Fellowship Program

Cancer Control Research Program

Head and Neck Clinical Trials

Clinical Interests:

Head and Neck Cancer

Board Certified:

Hematology 1992

Medical Oncology 1991

Internal Medicine 1990

Degree(s): MD

University of Rochester School of Medicine, Rochester, NY 1986

Internship(s):

Residency:

Medical Center Hospital of Vermont, Burlington, VT, (Internal Medicine) 1986-89

Fellowship(s):

Beth Israel Hospital, Boston, MA, (Hematology/Oncology) 1989-92

Biography:

Dr. Davis received his BA in 1978 from Middlebury College and his MD in 1986 from the University of Rochester School of Medicine and Dentistry. After completing an internal medicine residency in 1989 at the Medical Center Hospital of Vermont (Burlington) he did his clinical and research fellowship at both the Harvard Medical School and Beth Israel Hospital. After graduating from the fellowship program in 1992, Dr. Davis joined the DHMC faculty as staff hematologist-oncologist at the VA Hospital in White River Junction, VT. In 1994 Dr. Davis joined the Outreach Program at the Dartmouth Hitchcock Medical Center and in 1996 he became Director of the Hem/Onc Fellowship Program and Director of the Oncology Outreach Program.

Research Interests:

Dr. Davis' major areas of research interest are: 1. Combined modality therapy of Head and Neck cancers; 2. Health care delivery system improvements: decentralized subspecialty care in rural areas; 3. Strategies for cancer education for fellows and continuing medical education for non-specialist physicians; 4. Computers in cancer care and education.

Selected Publications:

Davis TH, Fadul CE, Glantz MJ, Bator TM, Lewis LL, Bouchard PR, Gonzalez JL, Mamourian AC, Cole BF. Pilot phase II trial of temozolomide for leptomeningeal metastases: preliminary report. Proc ASCO 2003;22:115a (abstract 460).

Petty WJ, Dragnev KH, Pipas JM, Davis TH, Williams IR, Rigas JR. A phase I dose-escalation trial of docetaxel and gemcitabine given every other week with filgrastim for patients with solid tumors. Proc ASCO 2003;22:161a (abstract 645).

Petty WJ, Dragnev KH, Memoli VA, Davis TH, Nugent WC, William IR, Iwata KK, Hamilton M, Rigas JR, Dmitrovsky E. Cyclin D1 repression as a marker of erlotinib response in aerodigestive tract cancers. Proc ASCO 2004 (abstract 3093).

Petty WJ, Dragnev KH, Memoli VA, Ma Y, Desai NB, Biddle A, Davis TH, Nugent WC, Memoli N, Hamilton M, Iwata KK, Rigas JR, Dmitrovsky E. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers. Clinical Cancer Research 2004; 10(22):7547-54.

Colon-Otero G, Davis TH, Elkins S, Kosty MP, Mudad R, Niell HB, Wozniak AJ. Oncology Review Study Guide. The American Journal of Oncology Review 2004; 3 (11, Suppl. 10): 6-20.

Mailing Address:
Norris Cotton Cancer Center
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756